Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

CERILLIANT™ Fluvoxamine-D3 maleate Solution, 100 μg/mL in Methanol (as free base), Sold by MilliporeSigma™ Supelco™

Catalog No. 01001369 Shop All MilliporeSigma Supelco Products
Change view
Click to view available options
Quantity:
1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
01-001-369 1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 01-001-369 Supplier MilliporeSigma Supelco Supplier No. F0451ML
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Certified reference material

A stable-labeled internal standard suitable for quantification of fluvoxamine levels in biological samples for testing applications by mass spectrometry in clinical toxicology, forensic analysis, or urine drug testing. Fluvoxamine, sold under brand names such as Luvox™ or Faverin™, is a selective serotonin reuptake inhibitor (SSRI). This SSRI antidepressant is used in the treatment of disorders ranging from major depressive and post-traumatic stress to obsessive-compulsive and anxiety.
TRUSTED_SUSTAINABILITY

Specifications

CAS 67-56-1, 1185245-56-0
Linear Formula C15H18D3F3N2O2 · C4H4O4
UN Number UN 1230 - class 3 - PG 2 - Methanol, solution
Concentration 100 μg/mL in methanol (as free base)
Formula Weight 437.43
Packaging Ampule
Quantity 1 mL
Flash Point 9.7°C (49.5°F) - closed cup

CERILLIANT is a registered trademark of Cerilliant Corporation

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.